Schleifenbaum L, Stern J, Driebe JC, Wieczorek LL, Gerlach TM, Arslan RC, et al
Cross-reactivity between different incretin-based therapies has been reported, suggesting that patients with allergies to other GLP-1 receptor agonists should be approached with extreme caution if tirzepatide therapy is being considered
Furthermore, a real-world retrospective study comparing the compliance of patients receiving different GLP-1RAs for the treatment of hyperglycemic found that even if GLP-1RA weekly preparations were used, there were still differences in compliance [171]
The anti-tubercular activity of simvastatin is mediated by cholesterol-driven autophagy via the AMPK-mTORC1-TFEB axis
Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs
If youre starting a GLP-1, heres how to recognize (and hopefully minimize) the most common side effects